IRIS PubliCatt

Baldin, Gianmaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 611
EU - Europa 380
AS - Asia 153
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 607
SE - Svezia 140
CN - Cina 86
IT - Italia 84
FR - Francia 48
DE - Germania 44
IN - India 31
IE - Irlanda 26
SG - Singapore 24
RU - Federazione Russa 11
FI - Finlandia 6
GB - Regno Unito 5
PL - Polonia 5
UA - Ucraina 5
BE - Belgio 3
AE - Emirati Arabi Uniti 2
CA - Canada 2
CI - Costa d'Avorio 2
CL - Cile 2
IR - Iran 2
JP - Giappone 2
MX - Messico 2
TW - Taiwan 2
BG - Bulgaria 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
TR - Turchia 1
Totale 1.151
Salva come PNG Salva come JPEG
Città #
Chandler 189
Ashburn 60
New York 42
Dublin 26
Redmond 25
San Mateo 25
Nanjing 22
Rome 19
Singapore 18
Boston 17
Dearborn 15
Princeton 15
Redwood City 15
Cattolica 14
Milan 14
Wilmington 14
Marseille 10
Jacksonville 9
Beijing 7
Changsha 6
Moscow 6
Shenyang 6
Hefei 5
Jiaxing 4
Kraków 4
Nanchang 4
Tianjin 4
Washington 4
Augusta 3
Brussels 3
Fairfield 3
Guangzhou 3
Jinan 3
Lawrence 3
Los Angeles 3
Mountain View 3
Seattle 3
Abidjan 2
Ann Arbor 2
Fuzhou 2
Hebei 2
Helsinki 2
Leawood 2
Norwalk 2
Palermo 2
Pune 2
Tokyo 2
Andover 1
Ardabil 1
Baltimore 1
Bangalore 1
Boardman 1
Cambridge 1
Central District 1
Changchun 1
Chicago 1
Chongqing 1
Clearwater 1
Dubai 1
Esslingen am Neckar 1
Fabriano 1
Falkenstein 1
Florence 1
Fontainebleau 1
Hangzhou 1
Houston 1
Izmir 1
Kunming 1
Lancaster 1
London 1
Macao 1
Mumbai 1
New Delhi 1
Ottawa 1
Ovar 1
Parabiago 1
Philadelphia 1
Phoenix 1
Prineville 1
Riano 1
Rio Saliceto 1
Sacramento 1
Seongnam-si 1
Shanghai 1
Sofia 1
Sovicille 1
Taipei 1
Tappahannock 1
Toronto 1
Vittuone 1
Woodbridge 1
Wuhan 1
Yellow Springs 1
Zanjan 1
Totale 693
Salva come PNG Salva come JPEG
Nome #
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 99
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 83
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 78
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 71
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice 71
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy 69
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 67
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 66
Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice 66
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 66
Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016 62
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 56
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 55
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication 54
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study 54
Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: a multicenter retrospective cohort study 53
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 51
Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice 48
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 7
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV 7
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice 6
Totale 1.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020106 0 3 3 2 4 20 15 5 1 8 43 2
2020/202168 6 2 3 0 9 5 2 1 4 13 17 6
2021/2022155 4 0 4 24 5 6 0 27 3 15 25 42
2022/2023438 63 65 38 61 24 46 25 40 54 1 11 10
2023/2024221 13 40 4 20 4 79 6 6 1 8 21 19
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 1.189